Literature DB >> 28777099

Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved.

Kimberley W J van der Sloot1, Marzyeh Amini, Vera Peters, Gerard Dijkstra, Behrooz Z Alizadeh.   

Abstract

Inflammatory bowel diseases consisting of Crohn's disease and ulcerative colitis are chronic inflammatory diseases of the gastrointestinal tract. In addition to genetic susceptibility and disturbances of the microbiome, environmental exposures forming the exposome play an important role. Starting at birth, the cumulative effect of different environmental exposures combined with a predetermined genetic susceptibility is thought to cause inflammatory bowel disease. All these environmental factors are part of a Western lifestyle, suiting the high incidence rates in Europe and the United States. Whereas receiving breastfeeding, evidence of a Helicobacter pylori infection and vitamin D are important protective factors in Crohn's disease as well as ulcerative colitis, increased hygiene, experiencing a bacterial gastroenteritis in the past, urban living surroundings, air pollution, the use of antibiotics, nonsteroidal anti-inflammatory drugs, and oral contraceptives are likely to be the most important risk factors for both diseases. Current cigarette smoking yields a divergent effect by protecting against ulcerative colitis but increasing risk of Crohn's disease, whereas former smoking increases chances of both diseases. This review gives a clear overview of the current state of knowledge concerning the exposome. Future studies should focus on measuring this exposome yielding the possibility of combining all involved factors to one exposome risk score and our knowledge on genetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28777099     DOI: 10.1097/MIB.0000000000001217

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  22 in total

1.  Westernized Diet is the Most Ubiquitous Environmental Factor in Inflammatory Bowel Disease.

Authors:  Mitsuro Chiba; Kunio Nakane; Masafumi Komatsu
Journal:  Perm J       Date:  2019

Review 2.  Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives.

Authors:  Lie Zheng; Yong-Yi Ji; Xin-Li Wen; Sheng-Lei Duan
Journal:  World J Gastroenterol       Date:  2022-06-21       Impact factor: 5.374

Review 3.  Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions.

Authors:  John Gubatan; Steven Levitte; Akshar Patel; Tatiana Balabanis; Mike T Wei; Sidhartha R Sinha
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

4.  Uncovering the cause of ulcerative colitis.

Authors:  Ian C Roberts-Thomson; Robert V Bryant; Samuel P Costello
Journal:  JGH Open       Date:  2019-08-06

5.  Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].

Authors:  Julius Z H von Martels; Arno R Bourgonje; Marjolein A Y Klaassen; Hassan A A Alkhalifah; Mehdi Sadaghian Sadabad; Arnau Vich Vila; Ranko Gacesa; Ruben Y Gabriëls; Robert E Steinert; Bernadien H Jansen; Marian L C Bulthuis; Hendrik M van Dullemen; Marijn C Visschedijk; Eleonora A M Festen; Rinse K Weersma; Paul de Vos; Harry van Goor; Klaas Nico Faber; Hermie J M Harmsen; Gerard Dijkstra
Journal:  J Crohns Colitis       Date:  2020-06-19       Impact factor: 9.071

6.  Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management - a follow-up study in a private inflammatory bowel disease center (2003-2017).

Authors:  D B Cury; R Oliveira; M S Cury
Journal:  J Inflamm Res       Date:  2019-05-28

7.  Inflammatory Bowel Disease: Complexity and Variability Need Integration.

Authors:  Claudio Fiocchi
Journal:  Front Med (Lausanne)       Date:  2018-03-21

8.  IL22 Inhibits Epithelial Stem Cell Expansion in an Ileal Organoid Model.

Authors:  Bailey Zwarycz; Adam D Gracz; Kristina R Rivera; Ian A Williamson; Leigh A Samsa; Josh Starmer; Michael A Daniele; Luisa Salter-Cid; Qihong Zhao; Scott T Magness
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-07-04

9.  Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ).

Authors:  Kimberley Wilhelmina Johanna van der Sloot; Rinse Karel Weersma; Gerard Dijkstra; Behrooz Zaid Alizadeh
Journal:  J Gastroenterol       Date:  2018-08-14       Impact factor: 7.527

10.  Caesarean Delivery and Risk of Chronic Inflammatory Diseases (Inflammatory Bowel Disease, Rheumatoid Arthritis, Coeliac Disease, and Diabetes Mellitus): A Population Based Registry Study of 2,699,479 Births in Denmark During 1973-2016.

Authors:  Vibeke Andersen; Sören Möller; Peter Bjødstrup Jensen; Frederik Trier Møller; Anders Green
Journal:  Clin Epidemiol       Date:  2020-03-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.